Pulmonary Embolism—Current and Novel Approaches

Dear Colleagues,

In recent years, there have been significant advances in our understanding and management of patients with pulmonary embolism, a condition that continues to be a major challenge worldwide. Pulmonary embolism is the third most frequent cause for cardiovascular death and one of the leading causes of in-hospital mortality. In the past decade, there has been tremendous advancement in the field of invasive percutaneous therapeutic options for the treatment of complex cases, providing more specific options for the complex pulmonary embolism patient. Nonetheless, there are still many gaps in our knowledge regarding the optimal use of these novel techniques and their associated outcomes, as well as there still being a need to discuss future perspectives on the topic and unmet needs.

This Special Issue aims to bring focus to the topic of pulmonary embolism from leading scientists and clinicians around the world in order to share their latest insights on the developments, methods for diagnosis, and novel treatments in the field. This issue will include original research and reviews relating to the epidemiology, diagnosis, risk stratification, and treatment of venous thromboembolic disease and specifically pulmonary embolism.

We are pleased to invite you take part in this Special Issue focusing on pulmonary embolism and look forward to receiving your contributions.

Prof. Dr. Roy Beigel
Prof. Dr. Shlomi Matetzky
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.